NHIA 2026 Home Infusion Conference Apr 18 to 22

NHIA 2026 Home Infusion Conference to Convene Industry Leaders in Denver

The NHIA 2026 Home Infusion Conference will take place from April 18 to April 22, 2026, at the Colorado Convention Center in Denver, Colorado. Organized by the National Home Infusion Association (NHIA), the event is recognized as one of the leading gatherings for the home and alternate site infusion industry in the United States.

Hosted at the Colorado Convention Center (700 14th St, Denver, CO 80202), the five-day conference will bring together providers, pharmacists, nurses, manufacturers, distributors, policymakers, and health system executives to examine the evolving landscape of home-based infusion therapy. Additional event details are available through the official conference website at https://conference.nhia.org/ and venue information at https://denverconvention.com/.

A Central Forum for the Home Infusion Industry

The NHIA Home Infusion Conference serves as the association’s flagship annual meeting, offering education, policy discussion, and an expansive exhibit hall focused exclusively on home and specialty infusion. The event attracts a broad cross-section of stakeholders, including:

– Home infusion pharmacies and providers
– Specialty pharmacies
– Pharmaceutical manufacturers
– Medical device and infusion pump companies
– Compounding and sterile preparation suppliers
– Group purchasing organizations
– Reimbursement and compliance experts

As home infusion therapy becomes an increasingly vital component of healthcare delivery, the conference functions as a strategic platform for addressing regulatory shifts, reimbursement models, accreditation requirements, and technological advancements.

The National Home Infusion Association, headquartered in the United States, represents companies that provide infusion therapies to patients in home and alternate site settings. These therapies include antibiotics, biologics, chemotherapy, parenteral nutrition, immunoglobulins, and other specialty medications that require intravenous or subcutaneous administration outside of acute care hospitals.

Industry Context: Growth in Home-Based Care

The 2026 conference comes at a pivotal time for the home infusion sector. Healthcare systems across the United States are under pressure to reduce inpatient costs, improve patient outcomes, and expand value-based care delivery. Home infusion aligns with these goals by shifting complex therapies from hospitals to lower-cost, patient-centered environments.

Several macro trends are shaping the industry:

Shift from Hospital to Home

Advances in portable infusion technology and remote monitoring tools have enabled more therapies to be safely administered at home. Hospitals and payers increasingly view home infusion as a mechanism to reduce readmissions and shorten inpatient stays. As a result, demand for qualified home infusion providers continues to rise.

Aging Population and Chronic Disease

An aging U.S. population and the increasing prevalence of chronic conditions such as autoimmune disorders, cancer, and gastrointestinal diseases are expanding the need for long-term infusion therapies. Biologic drugs and specialty medications, many of which require infusion delivery, represent a significant and growing share of pharmaceutical spending.

Reimbursement and Regulatory Developments

Medicare’s home infusion therapy benefit and ongoing adjustments to reimbursement policies remain central topics for providers and manufacturers. Compliance with U.S. Pharmacopeia (USP) standards for sterile compounding, evolving accreditation requirements, and state-level regulatory oversight also contribute to a complex operational environment.

The NHIA 2026 Home Infusion Conference is expected to address these policy and reimbursement issues in detail, providing guidance for providers navigating changing federal and commercial payer frameworks.

Education and Clinical Advancement

Clinical education is a cornerstone of the NHIA conference. Pharmacists, nurses, and clinical managers attend sessions covering infection prevention, vascular access device management, antimicrobial stewardship, and specialty drug administration protocols.

With specialty pharmaceuticals representing one of the fastest-growing segments in healthcare spending, infusion providers must remain current on handling, storage, and patient management practices. Educational tracks typically emphasize patient safety, quality assurance, and performance metrics tied to payer expectations.

The conference also serves as a forum for sharing data-driven outcomes that demonstrate the effectiveness and cost-efficiency of home infusion compared to hospital-based care.

The Exhibit Hall: Technology, Devices, and Supply Chain

A significant feature of the NHIA 2026 Home Infusion Conference will be its exhibit hall, where manufacturers and service providers present products and solutions tailored to the infusion market.

Key sectors represented typically include:

– Infusion pumps and administration sets
– Sterile compounding equipment and cleanroom technologies
– IV supplies and disposables
– Specialty pharmaceutical manufacturers
– Pharmacy software and workflow management systems
– Cold chain and logistics providers

Supply chain resilience remains a top concern for the industry following recent global disruptions. Manufacturers and distributors are expected to showcase innovations designed to enhance reliability, improve tracking, and ensure product integrity.

For vendors, the conference offers direct access to decision-makers from independent home infusion companies, regional providers, and national specialty pharmacy networks.

Economic Impact and Strategic Importance

Hosting the NHIA 2026 Home Infusion Conference at the Colorado Convention Center underscores Denver’s role as a national hub for major healthcare and trade events. Multi-day medical conferences contribute to local economic activity through hotel occupancy, dining, transportation, and ancillary services.

Beyond its local economic impact, the conference holds broader strategic importance for the U.S. healthcare system. Home infusion therapy represents a critical component of efforts to control healthcare spending while maintaining high standards of care. As policymakers and payers continue to evaluate site-of-care optimization strategies, industry alignment and advocacy efforts—often coordinated through organizations like NHIA—are increasingly consequential.

The conference also facilitates business development and consolidation discussions. The home infusion market has experienced ongoing merger and acquisition activity as private equity firms and larger healthcare entities seek to expand their specialty pharmacy and infusion footprints.

Looking Ahead to April 2026

From April 18 to April 22, 2026, stakeholders across the home infusion ecosystem will gather in Denver to assess market conditions, regulatory frameworks, and emerging technologies shaping the future of care delivery.

As demand for home-based therapies accelerates, the NHIA 2026 Home Infusion Conference is positioned as a central meeting point for clinical leaders, policymakers, and industry executives navigating a rapidly evolving healthcare landscape. The event’s combination of policy dialogue, clinical education, and commercial engagement reflects the growing strategic role of home infusion within the broader continuum of care in the United States.